Effect of Virtual Reality on Pain and Anxiety During Pap Smear Testing
The Effect of Virtual Reality Transition on Pain and Anxiety Experienced During Pap Smear Testing
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
This randomized controlled pretest-posttest experimental study aims to evaluate the effect of virtual reality (VR) on pain and anxiety levels experienced during Pap smear sampling. Although cervical cancer is largely preventable through regular screening, many women avoid Pap smear testing due to anxiety, fear of pain, and discomfort during gynecological examinations. Innovative, non-invasive interventions are needed to improve women's screening experiences and participation rates. The study will be conducted in a gynecology outpatient clinic with 60 women aged 18-65 years who meet the inclusion criteria and provide informed consent. Participants will be randomly assigned to either the intervention group (VR headset during the procedure) or the control group (standard care). Women in the intervention group will watch a 360° relaxing nature video during the Pap smear procedure. Data will be collected using a Personal Information Form, the State Anxiety Inventory, and the Visual Analog Scale (VAS). The findings may support integrating VR into clinical practice to enhance patient comfort during screening procedures.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 3, 2026
CompletedFirst Posted
Study publicly available on registry
March 10, 2026
CompletedStudy Start
First participant enrolled
March 10, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 10, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 10, 2026
March 10, 2026
March 1, 2026
2 months
March 3, 2026
March 9, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Pain level during Pap smear procedure
Pain intensity experienced during the Pap smear procedure will be measured using the Visual Analog Scale (VAS). The VAS is a 10-cm scale ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain intensity.
Immediately after completion of the Pap smear procedure (within 5 minutes post-procedure).
State anxiety level
Anxiety level will be assessed using the State Anxiety Inventory before and after the Pap smear procedure. Higher scores indicate higher anxiety levels.
Immediately before the procedure and immediately after the procedure.
Study Arms (2)
Virtual Reality Group
EXPERIMENTALParticipants will watch a 360° relaxing nature video through a VR headset during the Pap smear procedure.
Control Group
NO INTERVENTIONRoutin nursing care
Interventions
Participants will watch a 360° relaxing nature video through a VR headset during the Pap smear procedure.
Eligibility Criteria
You may qualify if:
- Women aged 18-65 years
- Scheduled for a Pap smear procedure
- Able to communicate in Turkish
- Able to understand and complete the study questionnaires
- Willing to provide written informed consent
- No visual or hearing impairment preventing the use of a VR headset
You may not qualify if:
- History of severe motion sickness or vertigo
- Diagnosed psychiatric disorder affecting anxiety assessment
- Use of anxiolytic or sedative medication within 24 hours prior to the procedure
- Presence of acute pelvic pain or active vaginal infection
- Previous participation in this study
- Any condition preventing safe use of a VR headset
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Buse Güney
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Participants will be blinded to the study hypothesis. The intervention group will receive virtual reality during the Pap smear procedure, while the control group will receive standard care.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 3, 2026
First Posted
March 10, 2026
Study Start
March 10, 2026
Primary Completion (Estimated)
May 10, 2026
Study Completion (Estimated)
May 10, 2026
Last Updated
March 10, 2026
Record last verified: 2026-03